n 1915 Marie Krogh first described the single-breath diffusing capacity of the lung for carbon monoxide (DL CO SB ), proving that passive diffusion alone could explain gas transport across the air-blood barrier and putting to rest the once popular belief that the alveolar epithelium functioned like a gland, actively secreting oxygen (O 2 ) into capillary blood. 1 Today, the test is recognized as a unique screening tool to examine the integrity of the air-blood barrier. In the United States, the average pulmonary function laboratory performs Ͼ800 DL CO SB tests per year. 2 The "diffusing capacity" is not the best choice of term since it is a conductance (the inverse of resistance) rather than a "capacity," and CO uptake involves not only passive diffusion but also chemical binding with hemoglobin (Hb). Outside North America it is called the transfer factor.
PHYSIOLOGIC FACTORS AFFECTING DL CO

SB
COMPONENTS OF DL CO
SB
The pathway for CO from air to blood (Figures 57-1 and 57-2) classically consists of two resistances in series. 3 The first is 1/D M , or the "extra-Hb resistance," due to the diffusing capacity of the alveolar membrane (D M ). This resistance is the result of passive diffusion through an astonishingly thin minimal tissue barrier (Ͻ0.6 m), consisting of the alveolar epithelial type 1 cell, a fused basement membrane, and a capillary endothelial cell. Additionally, there is an intracapillary component consisting of an "unstirred" plasma layer surrounding the red cell, 4 the red cell membrane, and cytoplasm.
The second resistance (1/V C ), or the "intra-Hb resistance," is owing to the CO conductance within the red cells in the pulmonary capillary blood. 3 The rate (mL/min/mm Hg) of chemical combination of CO with Hb (), per mL of whole blood, measured in vitro using venous blood at a standard Hb concentration, estimates the finite reaction rate of CO binding with Hb. Knowing the total volume of capillary blood exposed to alveolar air (V C ), the overall conductance of the blood for CO transfer (V C ) can be calculated (see (y axis) versus 1/ (x axis) yields a straight line where the y intercept is 1/D M and the slope is 1/V C . 3 The measurement of V C depends critically on accurate measurements of , which must be indirectly estimated using in vitro mixing chambers. 3 Furthermore, depends directly on the capillary hematocrit (Hct), which is assumed to be the same as systemic venous values but is actually substantially lower in
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David J. Cotton, Brian L. Graham the pulmonary capillaries than in the systemic circulation. 5 In normal subjects D M is very large, so most of the diffusive resistance is a result of the chemical combination of CO with Hb (see . Diseases that damage the alveolarcapillary membrane likely reduce both D M and V C because the alveolar epithelium and pulmonary capillaries are anatomically in such close proximity. Measuring the components of DL CO SB (D M and V C ) usually adds little additional, useful clinical information, particularly because of inaccuracies in estimating .
Although ignored in the classic analysis, part of the CO pathway involves gas-phase transport, by both convection and gas diffusion, from the more proximal airways to the more distal gas-exchanging bronchioles and alveoli (see . The mixing of a gas rich in CO and a tracer gas, helium (He), is neither instantaneous nor complete during inhalation and short periods of breath holding (t BH ). Time-dependent gradients in CO and He concentration ([CO] and [He] , respectively) develop in the lung periphery, distal to terminal bronchioles. 6 This lowers the [CO] at the air-blood interface and, by reducing the effective driving pressure for CO, lowers DL CO SB . The simultaneously created, time-dependent gradients for He result in worsening of ventilation inhomogeneity. This incomplete gas-phase mixing creates a third "gas-mixing" conductance, called G MIX , 7 which is normally so large that it does not affect the pathway for CO. 8 However, when gas-phase mixing worsens, G MIX decreases. 9, 10 In this case, the pathway for CO becomes
PULMONARY CAPILLARY RECRUITMENT
DL CO SB is not maximal in normal, seated subjects at rest because the pulmonary capillary bed is not fully recruited, that is, open or distended. Capillaries behave like millions of highly collapsible tubes connected in parallel and stacked in sheets one above the other. Gravitational forces create a gradient in pulmonary perfusion and, hence, also in diffusion that is greater in the base than the apex of the lung. 11 There are three zones of perfusion that are not only influenced by the prevailing alveolar pressure (P A ) but are also affected by pulmonary artery pressure (P a ) and pulmonary venous pressure (P v ). In zone III, at the bottom of the lung where P a and P v exceed P A , capillaries are mostly recruited and distended. With distance down this zone, capillaries become more distended, thus increasing regional V C . In zone II in the midlung region, where P a is higher than P v , but P A exceeds P v , a waterfall or sluice effect develops whereby capillary blood flow depends on the difference between P a and P A . For capillaries situated gravitationally lower down this zone, there is progressively greater recruitment or distention, thus increasing regional V C and D M . In zone I at the lung apex, where P A exceeds both P a and P v , there is minimal blood flow, so the capillaries are nearly empty, and regional V C and D M approach zero. These factors determine the degree of pulmonary capillary recruitment in response to physiologic stimuli and in lung diseases. 
HEMOGLOBIN
ALVEOLAR VOLUME
If the normal lung were a collection of spheres and if DL CO SB were directly proportional to the surface area of the spheres, then DL CO SB would vary with alveolar volume (V A ) 2/3 . In reality, capillary surface area, and hence DL CO SB , is preserved with decreasing V A because the alveolar-capillary membrane tends to fold, rather than shrink, as lung volume decreases. Partitioning of the longitudinal distribution of pulmonary vascular resistance reveals that the resistance of the "alveolar segment" decreases with decreasing V A from total lung capacity (TLC) to functional residual capacity (FRC) 19 because pulmonary capillaries widen, thus increasing V C with decreasing V A . Hence, decreasing V A from TLC to 50% of inspiratory capacity (IC) decreases DL CO SB minimally. 17 More recently, use of rapidly responding analyzers for both CO and a tracer gas (methane) improves testing by more accurately defining the dead space washout of CO, so that the timing of the alveolar sample is appropriate (see Figure 57 -3, sample A).
PITFALLS IN CONVENTIONAL DL CO
SB COMPUTATIONAL ERRORS
Since the Krogh equation is valid only when inhalation and exhalation are infinitely fast, conventional methods are accurate only when single breath approaches this ideal.
Deviations from the ideal cause computational errors in DL CO SB because the Krogh equation does not accurately describe the changes in alveolar [CO] during either inhalation or exhalation, even assuming a homogeneous lung model. This is an important pitfall because only about 70% of the adjusted t BH actually occurs during apnea at TLC, even under optimal conditions. At least 10% of the adjusted t BH occurs during inhalation, whereas at least an additional 20% usually occurs during exhalation (see . Rapid exhalation is not mandated because of limitations in testing equipment and patient cooperation or capability. 14, 25 Decreasing the exhaled flow rate increases DL CO SB23,24,28,29 because a greater proportion of CO uptake occurs at lung volumes below TLC when CO is disappearing from the lung, not only by diffusion into the blood but also by exhalation. When the inhaled flow rate decreases, DL CO SB decreases because the adjusted t BH is represented mostly by inhalation, during which time CO has had insufficient time to reach the air-blood barrier. 29 Decreasing t BH markedly reduces the proportion of time that actually occurs during apnea, and, hence, the Krogh equation is no longer mathematically accurate. Its use has variable effects on DL CO SB , depending on the measurement of the adjusted t BH , the amount of time spent during inhalation and exhalation, and the details of alveolar sample collection. DL CO SB increases with decreasing t BH using Ogilvie' s method, 23 whereas Jones and Meade' s method, using small (85 mL) alveolar samples, is less affected by decreasing t BH in normal subjects. 27 The size and timing of the alveolar sample collection cause further variability. Collecting the sample too early will include V D in the alveolar gas, causing DL CO SB to be grossly underestimated because CO-rich dead space gas contaminates the alveolar sample (see Figure 57-3, sample B) . 30 
DL CO
SB is slightly overestimated if V D is not subtracted from V A . In the conventional DL CO SB method a fixed washout volume is used (0.75-1.0 L), 14 which assumes that this volume is adequate to wash out V D . However, the washout volume actually exceeds 1.0 L in 26% of cases when measured using a rapidly responding analyzer. 31 Furthermore, DL CO SB is progressively overestimated the later in exhalation that an alveolar sample of fixed size is collected because a greater proportion of the adjusted t BH occurs during exhalation (see Figure 57-3) . 28, 29 When the entire alveolar sample is collected, DL CO SB is overestimated 32 because Ogilvie' s adjusted t BH (see , which stops at the onset of sample collection, 23 ignores CO diffusion into the blood during sample collection.
14 Changes in volume (upper graph) and continuous analysis of [CO] and [He] (lower graph) are plotted versus time (s) on the x axis. At RV, seated subjects rapidly inhale test gas to TLC and, after breath holding, exhale smoothly. Recommendations include inhalation time Ͻ2.5 s (Ͻ4 s in COPD patients); inspired volume Ͼ90% of VC; adjusted t BH of 9-11 s ( Jones adjusted t BH preferred rather than Ogilvie' s method; see text); P A not measured, but changes minimized by the patient relaxing against a closed glottis or valve during t BH ; smooth exhalation, but not necessarily forced; dead space washout of 0.75-1.0 L (reduced to 0.5 L if VC Ͻ 2.0 L); collection of an alveolar gas sample of 0.5-1.0 L (sample A) with sample collection time Ͻ4.0 s); no smoking for 24 hr prior to testing. Use of rapidly responding analyzers prevents collecting the sample too early (sample B), which causes contamination of the alveolar sample with dead space gas, lowering DL CO SB , 30 whereas collecting alveolar gas later in exhalation (sample C) increases DL CO SB28 (see text).
LUNG VOLUME
Measuring DL CO SB /V A , the so-called Krogh' s constant, does not compensate for the effect of changing V A because this ratio is not constant as lung volume decreases. With decreasing V A , DL CO SB decreases far less than V A , so DL CO SB /V A actually increases, and the increase is much greater when the single breath is immediately preceded by a deep breath or sigh. 33 For maneuvers preceded by a deep breath, DL CO SB /V A increases by 15% when IC decreases from 100 to 50%. 33 The practice of using DL CO SB /V A to "correct" DL CO SB for variations in lung volume is therefore not recommended.
INERT GAS DILUTION
The principle of inert gas dilution 23, 26 Figure 57 -3, sample A vs C) and when a smaller versus larger alveolar gas sample is collected after a fixed washout volume. Whenever F A He t1 increases, V A decreases (see Equation 57-7) and F A CO t0 increases (see . 31 In patients with airflow obstruction, V A is underestimated by 7 to 9% when measured from a 1.0 L alveolar sample and by 9 to 13% when measured from a 0.2 L alveolar sample. 9 The two errors (measuring V A and F A CO t0 ) have opposite effects on DL CO SB , but if F A CO t1 (see Equations 57-4 and 57-6) were the same in the calculation, the net effect is an increase in DL CO SB because the CO decay term is logarithmic (see . In practice, the overall effect is complicated since the [CO] in the alveolar gas sample (F A CO t1 ) also varies with the size and timing of sample collected (see Figure 57- 3).
ALVEOLAR PRESSURE
P A , not routinely monitored, is assumed to be atmospheric P B (see . When the actual mean P A differs from P B , computational errors occur (about 5-10%), which spuriously increase DL CO SB when P A is higher than P B (Valsalva' s maneuver) and decrease DL CO SB when P A is lower than P B (Müller' s maneuver). However, the dominant effect of changes in P A on DL CO SB is in the opposite direction and is caused by a direct effect on the pulmonary capillaries. A Müller maneuver creates subatmospheric P A , which increases DL CO SB by increasing pulmonary capillary recruitment. DL CO SB (corrected for changes in P B ) increases by 10 to 20% if P A is reduced only during slow constant VC inhalation 34, 35 and by 6% if subjects actively inspire against a closed glottis or valve near TLC during breath holding. 36 Alternatively, increasingly positive P A (Valsalva' s maneuver) during breath holding decreases cardiac output 37 and V C , 36 thus decreasing DL CO SB by about 20%. 36 Highly positive P A during rapid, forced exhalation also lowers DL CO SB , particularly with increasing airflow obstruction. 38 
REPRODUCIBILITY
Large variability in the conventional DL CO SB exists, despite rigid standardization, 14,25 which, in practice, is not achieved in one-third of healthy subjects, 39 and success is even less likely in patients with lung disease. Predicted values for DL CO SB vary markedly and need to be chosen to match results from a locally studied healthy population. The limits for "normality" should be based on the 95% confidence limits, which result in a wide range for normality (about 70-130% predicted). The source of this wide variability is threefold. First, there is biologic variability resulting from the effects of changes in Hb, P A , cardiac output, COHb, and CO back-pressure, as well as the effects of the circadian rhythm and variations during the normal menstrual cycle in women. DL CO SB decreases by 9% by the third day of menses compared with the week preceding menses. 14 Second, there is variability related to how the single breath is performed, that is, variations in the inhaled and exhaled flow rates, V A , volume history, t BH , and the speed, size, FIGURE 57-4 Single breath distribution of an inert gas; Plot of a tracer gas (He) (y axis) versus exhaled volume (x axis) in a normal subject for a single breath consisting of slow (0.5 L/s) inhalation of test gas (10% He) from RV to TLC and slow (0.5 L/s) continuous exhalation back to RV, with no breath holding. The Fowler method measures anatomic dead space (V D ). The phase III slope for He, measured by linear regression through the middle third of the exhaled volume, is an index of ventilation inhomogeneity. V A is measured using a mass balance equation applied at end-exhalation (time ϭ t 2 ), which in this example is RV: which assumes that the mass of He entering the lung during inhalation beginning at t 0 is equal to the mass of He leaving the lung during exhalation, plus the mass left in the lung at end-expiration. The method assumes that average He concentration of the gas remaining in the lung at RV is the [He] measured at end-exhalation, that is, He(t 2 ). 
VALUE OF CONVENTIONAL DL CO SB TESTING IN CLINICAL PRACTICE OBSTRUCTIVE LUNG DISEASES
A low DL CO SB may help in establishing a diagnosis of emphysema since loss of overall alveolar surface area reduces DL CO SB , and the decrease correlates with emphysema severity, detected by high-resolution computed tomography (HRCT). 41 In the seated position, DL CO SB is more sensitive to lower lobe and diffuse emphysema but does not reliably detect bullous emphysema in the lung apex. 42 A very low DL CO SB , along with a low forced expiratory volume in 1 second (FEV 1 ), predicts poor survival for chronic obstructive pulmonary disease (COPD) patients after lung volume reduction surgery. 43 DL CO SB testing plays a limited role in detecting emphysema in patients with severe airflow obstruction because the test may be low in patients with little emphysema (by HRCT) 44 but can be normal in patients with a substantial degree of emphysema. 45 The test is either normal or low 46 in patients with cystic fibrosis (CF). It may help to separate asthma patients from COPD patients since DL CO SB in asthma patients is either normal 9 or may be increased 47 as a result of either computational errors caused by the decreased exhaled flow 31 or more negative inspiratory pressure during forced inhalation. 35 
INTERSTITIAL LUNG DISEASE
DL CO
SB is reduced early in the course of chronic interstitial lung diseases (ILD) when the chest radiograph may still be normal, 48 presumably because the disease process both thickens the air-blood barrier and decreases the number of capillaries participating in gas diffusion. The decrease in DL CO SB correlates with overall lung involvement by HRCT 49 and appears more sensitive than changes in lung volume in screening patients at risk for pneumoconiosis. 40 DL CO SB decreases in acute ILD, such as Mycoplasma pneumonia, early lung transplant rejection, and bronchiolitis obliterans, and also decreases in chronic ILD, which occurs in scleroderma, rheumatoid arthritis, systemic lupus erythematosus, idiopathic pulmonary fibrosis, sarcoidosis, hypersensitivity pneumonitis, lymphangioleiomyomatosis, and ILD induced by drugs, such as nitrofurantoin, bleomycin, or amiodarone. DL CO SB may be useful in the detecting and following the progression of drug-induced lung disease. 50 
PULMONARY VASCULAR OBSTRUCTION
DL CO
SB is decreased by pulmonary vascular obstruction (PVO), which occurs following lymhangiography, 51 talc emboli in talc granulomatosis, 52 recurrent leukocyte sequestration as a result of chronic hemodialysis, 53 and pulmonary emboli (PE) of either thrombotic 54 or tumor origin. Although the test has no current role in the investigation of suspected PE, a low value should raise the suspicion of this diagnosis. DL CO SB is decreased more in PE, the greater the PVO, 54 and is also decreased in patients with chronic unresolved PE and primary pulmonary hypertension. 55 However, in the seated position at rest, the reduction in DL CO SB may be masked by compensatory recruitment or distention of the pulmonary capillaries in lung zones spared from vascular occlusion. 56 "Static pulmonary capillary blood," distal to obstructed pulmonary vascular segments, could cause the diffusing capacity to decrease from the first to the fifth of five sequential single breaths, 57 but this method of PE detection needs further validation.
CARDIOVASCULAR DISEASE
When pulmonary vascular resistance (PVR) is normal, DL CO SB changes according to the principles that govern pulmonary capillary recruitment. DL CO SB increases when cardiac output or inflow pressure (P a ) increases (exercise, left-to-right shunt) or when outflow pressure (P v ) increases (mild congestive heart failure [CHF] or early mitral stenosis). 58 However, DL CO SB decreases when P a decreases (pulmonary stenosis, 59 or systemic venodilation following administration of nitroglycerin 60 ). When mitral stenosis or CHF becomes chronic, pulmonary vascular remodeling increases PVR, leading to a decrease in DL CO SB . 59 The vascular remodeling appears fixed in CHF since the low DL CO SB does not improve following heart transplantation. 61 
"ISOLATED" LOW DL CO
SB
When DL CO SB is low, but lung function is otherwise normal, consider the following possibilities: anemia, 13 focal emphysema, 62 early interstitial lung disease, 48 pulmonary vascular diseases, or undetected PE. 54 Unlikely factors include a decreased P a due to pulmonary stenosis 59 or systemic venodilatation, such as occurs with administration of a systemic vasodilator. 60 Rule out testing errors, including contamination of the alveolar sample with V D , slowing of inhaled flow, excessively long t BH , undetected Valsalva' s maneuver, underestimation of V A , or increases in COHb or CO backpressure due to smoking or repeated DL CO SB testing.
"ISOLATED" HIGH DL CO SB
When lung function is otherwise normal, but DL CO SB is increased, consider polycythemia 12 ; anxiety or exercise immediately preceding testing; "static" alveolar red cells, which occurs in patients with pulmonary hemorrhagic syndromes 63 ; increased body mass index, seen in obstructive sleep apnea 64 ; mild asthma 47 ; left-to-right shunts 59 ; or transiently increased P v (mild left heart failure or left atrial myxoma). Rule out testing errors including decreased exhaled flow rate; shortened t BH ; collection of the alveolar sample late in exhalation; undetected Müller' s maneuver; overestimation of F A CO to by underestimating the tracer gas dilution; or overestimation of V A .
STRESS TESTING TO RECRUIT V C
Most airway narrowing is patchy, so regional ventilation in more affected lung zones decreases, causing regional hypoxic pulmonary vasoconstriction (HPV), which diverts blood flow to more normal lung zones with relatively preserved regional ventilation. In the seated position at rest, compensatory capillary recruitment increases regional V C in relatively normal lung zones and, hence, limits the reduction in DL CO SB . However, HPV decreases the potential for further capillary recruitment, so the increase in DL CO SB , in response to interventions that normally fully recruit pulmonary capillaries, is reduced or abolished. Interventions that recruit Vc include the 15°head-down position, 34 exercise, 23 and negative inspiratory pressure. 35 In patients with CF, the increase in DL CO SB on assuming the 15°head-down position or in response to high negative inspiratory pressure is reduced breathing room air. 34 However, when HPV is eliminated by breathing 100% O 2 for 20 minutes, the positional change in DL CO SB is restored. 34 The positional increase in DL CO SB is also reduced in smokers with apical emphysema 65 and in patients with scleroderma, 66 sarcoidosis, 67 CHF, 68 and insulin-dependent diabetes. 69 The supine DL CO SB may therefore be more sensitive in the early detection of changes in the pulmonary vasculature, but few normal regressions for supine DL CO SB exist. 70
ALTERNATIVE DL CO SB TESTING METHODS
STEADY-STATE DL CO
The flow or uptake of CO is measured during steady-state tidal breathing and divided by the driving pressure, measured from the mean alveolar [CO] (P A CO). 71 The method, not in common use today, is usually measured during exercise because substantial errors in P A CO occur during resting tidal breathing.
REBREATHING DL CO
During rapid rebreathing, the decrease in [CO] from a rebreathing bag, measured using a rapidly responding CO analyzer, is assumed to reflect the uptake of CO from the lungs. The test, used mostly in normal subjects during exercise, 72 requires considerable subject cooperation, and the high airflow rate and lack of t BH actually impair diffusive gas mixing in the lung periphery (see Figure 57- This method 24, 38 assumes that the decrease in CO, measured only during constant flow, slow exhalation using rapidly responding analyzers, [74] [75] [76] represents the diffusion of CO across the air-blood barrier. However, the decrease in CO (Figure 57 -5) during exhalation is not only due to ongoing diffusion of CO into the blood but is also influenced both by transient, t BH -dependent gradients in [CO] within peripheral gas-exchanging units (see Figure 57 -2) 77 and by differences in [CO] among larger parallel lung units (due to regional differences in specific ventilation), which empty sequentially. 78 Therefore, ventilation inhomogeneity alone changes the slope for CO, and this effect is superimposed on true change in [CO] during exhalation owing to diffusion of CO into the blood. 77 The strategy of "correcting" the observed CO slope for the simultaneously measured slope of He (F A CO t1 (corrected) ϭ F A CO t1 · F A He t1 / F A He t0 ) does not satisfactorily eliminate the effects of ventilation inhomogeneity on the slope of the CO decay curve because ongoing CO diffusion into the blood causes the regional ratios . During exhalation, CO simultaneously leaves the alveolar space by both exhalation and by diffusion. The three equations (upper graph) are solved using an iteration technique that finds the single value of DL CO SB-3EQ that best predicts the observed amount of CO exhaled. Digital recording eliminates the need for physically collecting a gas sample because any "virtual" gas sample can be constructed. The entire alveolar gas sample provides the best estimate of DL CO SB of the average diffusion characteristics for the entire lung. To calculate an index of diffusion nonuniformity, D I (see Figure 57- 
DIFFUSING CAPACITY USING NITRIC OXIDE
Nitric oxide (NO) binds tightly with Hb with an affinity that is 400 times greater than that of CO. Diffusing capacity using nitric oxide (DL NO ) can be measured simultaneously with DL CO SB . It is fourfold larger than DL CO SB , independent of [O 2 ], and measures primarily D M in normal subjects. 79 However, in patients with lung disease, NO may, itself, alter lung diffusion because it is a potent pulmonary vasodilator, which inhibits HPV.
THREE-EQUATION SINGLE-BREATH DIFFUSING CAPACITY
The three-equation single-breath diffusing capacity (DL CO SB-3EQ ) method, which is a significant advance over conventional methods, 14 takes advantage of rapidly responding analyzers to continuously measure airflow rates, volume, CO, and a tracer gas, such as He or methane, throughout the single breath. By digitally recording all the data, the need to physically collect an alveolar gas sample is eliminated. A "virtual" sample of any size can be constructed and analyzed for either CO or He for any time period (see . Rather than using the single Krogh equation, three separate mass balance equations, each valid for the respective phases of inhalation, breath holding, and exhalation, are used to accurately describe the instantaneous changes in CO in the alveolar space throughout the entire single breath (see . 29 The equations are solved using a standard iteration technique, 80 which matches the predicted alveolar [CO] to that measured in "virtual" sample, consisting of all the exhaled alveolar gas (see . Successive iterations (usually Ͻ12) converge to a single DL CO SB-3EQ , which predicts the measured alveolar [CO] to within a tolerance of 0.1%. 80 The method assumes a homogeneous lung with a constant DL CO SB ; a single Fowler V D , measured for each breath (see Figure 57-4) ; a single homogeneously mixed alveolar space; and the same instantaneous changes in flow rate and V A , observed in the actual maneuver (see . 80 To measure V A more accurately [He] is monitored continuously, and a mass balance equation is used to describe the behavior of He throughout the entire single breath (see Figure 57-4) . 9, 80 Subjects perform a slow deep breath of room air from FRC to TLC, with 5 seconds of t BH , immediately before the DL CO SB test to eliminate variations in DL CO SB due to previous volume history, 22, 33 and the mean alveolar [CO] during the exhalation phase of the deep breath is used to adjust DL CO SB-3EQ for CO back-pressure and for COHb. 17 Since DL CO SB-3EQ is accurate for a homogeneous lung, despite changes in the way the single breath is performed or the way the alveolar sample is collected, 32 measurements can be obtained not only during large VC single breaths but also during submaximal "near-tidal" breaths with slow flow rates. 22, 33, 81 Since it is not necessary to strictly standardize t BH , as is the case using the conventional method, DL CO SB-3EQ is more precise and accurate in both normal subjects and patients with lung disease 31, 32, 46 and is independent of t BH in normal subjects. 9, 32, 81, 82 DL CO SB-3EQ could potentially decrease with decreasing t BH if worsening ventilation inhomogeneity increases 1/G MIX . In patients with significant airflow obstruction and ventilation inhomogeneity (COPD, asthma, and emphysema), DL CO SB-3EQ , measured from the entire alveolar sample, actually decreased with decreasing t BH during slow VC breaths, suggesting that the pathway for CO was significantly affected by an increase in 1/G MIX (see Figure 57 -2) during short periods of t BH . 9 When submaximal single breaths are performed near the tidal volume range, t BH -dependent inhomogeneity in gas mixing in the lung periphery increases dramatically, even in normal subjects, 73,81 thus potentially increasing 1/G MIX . However, no effect of decreasing t BH was found in either normal subject nonsmokers or smokers with normal forced exhaled flow rates when DL CO SB-3EQ was measured from the entire alveolar sample during slow inhalation-exhalation "near-tidal" breaths, performed from FRC to one-half IC with exhalation to RV. 10, 81, 82 In contrast, t BH -dependent ventilation inhomogeneity did affect DL CO SB-3EQ in normal subjects during near-tidal breaths when DL CO SB-3EQ was measured from the whole sample, but progressively increased in subsequent samples, so that it became relatively overestimated in sample 4. This effect is t BH dependent since it is greatest for single breaths without breath holding. D I is an index to quantify the degree to which DL CO SB-3EQ from each of the four samples deviates from DL CO SB-3EQ , measured from the entire sample (A, B, C, D). This variation is expressed as the root mean square difference of the four normalized DL CO SB-3EQ values. At a t BH of 0 s, D I is larger (42) in smokers versus nonsmokers (18) (left graph), but this difference is less after a t BH of 10 s (right graph). Data replotted from Cotton DJ et al. 10 separately from each of four equal alveolar samples, revealing temporal changes in DL CO SB-3EQ from early versus late samples. 82 DL CO SB-3EQ was reduced in the first alveolar sample, early in exhalation, but increased for alveolar samples later in exhalation (Figure 57-6) . 82 An index of diffusion nonuniformity (D I ) quantified how each of the four normalized DL CO SB-3EQ values deviated from DL CO SB-3EQ , measured from the entire alveolar sample and was measured using the root mean square difference. 10, 80 In normal, nonsmokers D I was exquisitely sensitive to t BH -dependent ventilation inhomogeneity in the lung periphery since D I was highest for single breaths without t BH and decreased dramatically with as little as 6 seconds of t BH (see Figure 57-6) . 82 For "near-tidal" breaths without t BH , the normalized phase III He slope was also increased in smokers, even although both the forced exhaled flows and the phase III slope of the standard, vital capacity and single-breath nitrogen washout were normal. 83 In this same group of smokers, D I was markedly increased for near-tidal breaths without t BH (see Figure 57 -6) and correlated with both age and packyears of smoking, 10 D I decreased with increasing t BH , in both smokers and nonsmokers, but the change was much greater in smokers. With increasing t BH the change in D I also correlated with the improvement of the phase III He slope. 10 The change in D I with t BH therefore quantifies an effect of an increase in 1/G MIX for single breaths within the tidal volume range and, may, along with changes in the phase III He slope, be useful in detecting smoke-induced inflammation in small airways. 10, 83 
SUMMARY
The conventional DL CO SB is a clinically useful, noninvasive tool to assess the integrity of the air-blood barrier but lacks sensitivity and specificity because it is affected by a number of physiologic variables and because, even for a homogeneous lung, the single, Krogh breath-holding equation causes maneuver-related computational errors that are disease specific. DL CO SB-3EQ avoids the computational errors of the conventional DL CO SB method because the mass balance equations accurately describe the behavior of both CO and He throughout a single breath. DL CO SB-3EQ is equally valid for maneuvers with varying flow rates, V A , and t BH . The advantages of slow inhalation-exhalation single breaths are that the distribution of an inert tracer gas can be measured simultaneously, the effects of wide swings in P A are minimized, and the maneuvers with short t BH can be performed equally well by both normal subjects and patients alike. The best estimate of DL CO SB-3EQ for the whole lung is obtained using the entire alveolar gas sample. When 1/G MIX increases, the pathway for CO is altered, causing changes, with t BH , both in DL CO SB-3EQ measured from the entire alveolar sample in patients with airflow obstruction and in D I in smokers with normal lung function.
